NCT05394831
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05394831
Title A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors J Ints Bio
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Chao Family Comprehensive Cancer Center, University of California Irvine Healthcare ACTIVE_NOT_RECRUITING Orange California 92868 United States Details
National Cancer Center RECRUITING Goyang-si Gyeonggi-do 03722 South Korea Details
Chungbuk National University Hospital RECRUITING Cheongju-si North Chungcheong 28644 South Korea Details
Seoul National University Hospital WITHDRAWN Seoul 03080 South Korea Details
Asan Medical Center RECRUITING Seoul 05505 South Korea Details
Samsung Medical Center RECRUITING Seoul 06351 South Korea Details
The Catholic University, St. Mary's Hospital NOT_YET_RECRUITING Seoul 06591 South Korea Details
Yonsei University Health System, Severance Hospital RECRUITING Seoul 10400 South Korea Details
The Catholic University, St. Vincent's Hospital RECRUITING Suwon 16247 South Korea Details
Faculty of Medicine Ramathibodi Hospital, Mahidol University NOT_YET_RECRUITING Ratchathewi Bangkok 10400 Thailand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field